Molecular epidemiology of human liver cancer: insights into etiology, pathogenesis and prevention from The Gambia, West Africa.
about
RNA-Seq profiling reveals novel hepatic gene expression pattern in aflatoxin B1 treated ratsMaraviroc, a CCR5 antagonist, prevents development of hepatocellular carcinoma in a mouse modelAdvances in chemical carcinogenesis: a historical review and prospectiveHepatitis B viral load and risk for liver cirrhosis and hepatocellular carcinoma in The Gambia, West Africa.Aflatoxin contamination in food and body fluids in relation to malnutrition and cancer status in Cameroon.DNA methylation changes in normal liver tissues and hepatocellular carcinoma with different viral infection.Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment.Non-viral causes of hepatocellular carcinoma.Hepatocellular carcinoma in the world and the middle East.Associations between Cox-2 rs20417 and rs5275 polymorphisms and the risk of hepatocellular carcinoma: a meta analysis.Non-viral factors contributing to hepatocellular carcinoma.Predictive power of hepatitis B 1762T/1764A mutations in plasma for hepatocellular carcinoma risk in Qidong, China.A locked nucleic acid clamp-mediated PCR assay for detection of a p53 codon 249 hotspot mutation in urine.Molecular characteristics of Hepatitis B and chronic liver disease in a cohort of HB carriers from Bamako, Mali.Seasonal variation in TP53 R249S-mutated serum DNA with aflatoxin exposure and hepatitis B virus infection.Lethal mutagenesis: targeting the mutator phenotype in cancer.TP53 R249S mutation, genetic variations in HBX and risk of hepatocellular carcinoma in The GambiaHapMap-based study of CIP2A gene polymorphisms and HCC susceptibility.Hepatitis B virus burden in developing countries.Association of PTEN gene polymorphisms with liver cancer risk.Aflatoxin exposure and viral hepatitis in the etiology of liver cirrhosis in the Gambia, West Africa.Trends in the incidence of primary liver cancer in Central Uganda, 1960-1980 and 1991-2005.Programmed cell death 4 (PDCD4) suppresses metastastic potential of human hepatocellular carcinoma cells.A review on aflatoxin contamination and its implications in the developing world: a sub-Saharan African perspective.Determinants of recent aflatoxin exposure among pregnant women in rural Zimbabwe.Epigenetic mechanisms regulating the development of hepatocellular carcinoma and their promise for therapeutics.Tumour-inducing viruses.Human oncogenic viruses: nature and discovery.Higher Levels of Aflatoxin M1 Contamination and Poorer Composition of Milk Supplied by Informal Milk Marketing Chains in Pakistan.Aflatoxin M1 in Pasteurized Milk in Babol city, Mazandaran Province, Iran.Preventing primary liver cancer: the HBV vaccination project in the Gambia (West Africa).Aflatoxins, hepatocellular carcinoma and public health.Frequent DNA methylation of MiR-129-2 and its potential clinical implication in hepatocellular carcinoma.Cancer screening and prevention in low-resource settings.Household dietary exposure to aflatoxins from maize and maize products in Kenya.
P2860
Q27324185-E33DB9C3-6B90-4493-88EC-EEA6EC196C40Q28484915-A5AFA05D-DEE9-4772-9130-726272F98DCFQ28756544-8F68A95A-70BE-41FE-BD6E-577DCE5E7C1AQ33633648-A8E27E51-651D-4B20-B65E-4CEBD5018771Q33644242-4B73DFDA-885A-4FCF-82A3-9B73CA9181AEQ33766987-CEAF5AC4-EF84-4D23-A68A-13CADA3CF97FQ33969253-F176904C-C28D-4022-B51B-E12629AA4CC2Q34041381-DD2EB471-DB32-471C-A248-B62D9AA38118Q34134967-131484B6-C0AC-45FD-808D-2D825D998B53Q34502076-8BD02D1C-1D12-4F78-8AF1-E381F70101A7Q34653639-23C821A4-7410-4330-BADA-14CF37573D0BQ35020474-E383C45E-FC1D-4BCF-8FB8-1B5F159E9F84Q35169299-B8E62AE3-0F04-4477-A90A-4A1B95B2CB62Q35492635-ED9AC65B-820C-4349-9A9F-8C44C392202DQ35579913-A7EAAE49-B78B-45EF-9D99-BBAAEE16EFA8Q35669158-FB3B0700-D94B-4FB9-A180-B410A27FC548Q36072589-65429344-4240-42A8-9F94-4F061B084CC6Q36110377-136815B3-287F-4CA6-AE51-B414465F9486Q36269649-E84D6CA5-2F52-42EC-9D61-CA0728B25F87Q36464903-8DC348DE-BA71-4EB5-95B3-698255674176Q36992263-05EE459C-8A44-471F-B660-B4F7E075463CQ37123546-A4ECE63F-4231-4EB9-A442-FCF4E7F1937AQ37249374-6F4E0B5B-C8DB-4710-BDDE-426C17BE6C5BQ38074200-7AE382BE-9A12-4508-94B6-C7BFDD123F86Q38763672-781C02B7-71F8-4BB4-BC09-9DD0A6A50C9CQ38857804-88ECBDC9-DD7B-4F9D-BC6D-706569993ECFQ38977066-A32496CD-B25F-4745-8886-8907967E00DEQ40046680-B62C7300-4C36-4BA4-A6B2-DCD820165F00Q40261273-60CFF856-460E-4621-91C2-058A35760C00Q41808463-660C1BAC-F4A2-4E4F-B383-6E70D3CEE70BQ42035960-D4D50089-6281-41F2-A09A-1544902812AAQ43224623-FC86E79D-B22A-473F-8004-97F88C670315Q43655837-46706579-3098-416C-AE90-77F1A8D72BFEQ53253182-248E01EA-7183-4B49-904A-FBFED9B8C546Q53824587-35B2A3FA-0234-4D9B-B1A9-97EA98993D9B
P2860
Molecular epidemiology of human liver cancer: insights into etiology, pathogenesis and prevention from The Gambia, West Africa.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Molecular epidemiology of huma ...... from The Gambia, West Africa.
@ast
Molecular epidemiology of huma ...... from The Gambia, West Africa.
@en
Molecular epidemiology of huma ...... from The Gambia, West Africa.
@nl
type
label
Molecular epidemiology of huma ...... from The Gambia, West Africa.
@ast
Molecular epidemiology of huma ...... from The Gambia, West Africa.
@en
Molecular epidemiology of huma ...... from The Gambia, West Africa.
@nl
prefLabel
Molecular epidemiology of huma ...... from The Gambia, West Africa.
@ast
Molecular epidemiology of huma ...... from The Gambia, West Africa.
@en
Molecular epidemiology of huma ...... from The Gambia, West Africa.
@nl
P2093
P356
P1433
P1476
Molecular epidemiology of huma ...... from The Gambia, West Africa.
@en
P2093
Ebrima Bah
Gregory D Kirk
Ruggero Montesano
P304
P356
10.1093/CARCIN/BGL060
P407
P577
2006-05-05T00:00:00Z